Back to Soleus Capital Management, L.P.

Soleus Capital Management, L.P.

All holdings · as of Dec 31, 2025

94 positions

CompanyClassValueShares% of portfolio
MBX Biosciences, Inc.MBXCommon Stock$12.90M408,9000.5%
Enliven Therapeutics, Inc.ELVNCommon Stock$15.79M1,025,0000.7%
Arcus Biosciences, Inc.$16.97M711,9830.7%
TENET HEALTHCARE CORP$18.38M92,5000.8%
CAPRICOR THERAPEUTICS, INC.$18.65M646,3900.8%
Invivyd, Inc.$19.04M7,708,7270.8%
Pharvaris N.V.$19.48M702,0520.8%
Inhibikase Therapeutics, Inc.$22.29M10,875,0000.9%
Edgewise Therapeutics, Inc.$22.58M910,0001.0%
Nurix Therapeutics, Inc.$23.13M1,219,3941.0%
TELEFLEX INC$23.19M190,0001.0%
EDAP TMS S A$24.05M7,309,2541.0%
Kiniksa Pharmaceuticals International, plc$24.21M587,0001.0%
NEUROCRINE BIOSCIENCES INC$24.96M175,9821.1%
RAPT THERAPEUTICS INC$25.88M764,0001.1%
ARGENX SE$26.68M31,7261.1%
Vericel Corp$27.51M764,0001.2%
Inspire Medical Systems, Inc.$27.61M299,3991.2%
Alnylam Pharmaceuticals Inc$27.84M70,0001.2%
VAXCYTE, INC.$28.10M608,9581.2%
Immunovant, Inc.IMVTCommon Stock$28.22M1,110,0001.2%
United Therapeutics Corp$29.23M60,0001.2%
GERON CORP$30.74M23,290,0001.3%
GSK PLC$31.34M639,0001.3%
LivaNova PLC$34.92M567,5001.5%
Alkermes plc.$37.00M1,322,3641.6%
ANI PHARMACEUTICALS INC$38.38M486,2431.6%
Axogen, Inc.$39.50M1,206,8551.7%
NeuroPace Inc$41.74M2,703,2081.8%
Insulet Corp$42.64M150,0001.8%
Mirum Pharmaceuticals, Inc.$45.31M573,6141.9%
Syndax Pharmaceuticals Inc$47.21M2,247,1102.0%
ORGANOGENESIS HOLDINGS INC.ORGOCommon Stock$51.73M9,985,9512.2%
Twist Bioscience Corp$59.06M1,861,8022.5%
AMICUS THERAPEUTICS INC$74.15M5,207,2843.1%
Beta Bionics, Inc.$77.23M2,534,5653.3%
Globus Medical Inc$77.44M887,0003.3%
BioMarin Pharmaceutical Inc$78.45M1,320,0003.3%
Dexcom Inc$86.09M1,297,0943.7%
TG Therapeutics Inc$93.58M3,139,3124.0%
Praxis Precision Medicines, Inc.$106.98M362,9664.5%
NovoCure Ltd$110.30M8,530,6654.7%
Celcuity Inc.CELCCommon Stock$180.36M1,808,2587.7%
Krystal Biotech, Inc.$232.01M941,0599.8%
← PrevPage 2 of 2Next →